
Apple
 is opening its ResearchKit platform to developers and researchers who 
can use the tool to learn more about patient diseases and conditions, 
like Parkinson's and diabetes.
The
 company announced ResearchKit in March, which collects data from 
patients via the iPhone. People with certain conditions can opt in to 
participate in various clinical studies and surveys (daily, weekly, 
monthly, etc.) that can be evaluated and analyzed by medical 
researchers. The goal is to ultimately improve patients' health and the 
ability to care for them.
Apple
 is opening its ResearchKit platform to developers and researchers who 
can use the tool to learn more about patient diseases and conditions, 
like Parkinson's and diabetes.
The
 company announced ResearchKit in March, which collects data from 
patients via the iPhone. People with certain conditions can opt in to 
participate in various clinical studies and surveys (daily, weekly, 
monthly, etc.) that can be evaluated and analyzed by medical 
researchers. The goal is to ultimately improve patients' health and the 
ability to care for them.
The
 move will allow medical researchers worldwide to collect more data 
about diseases on a larger scale. For those interested in participating 
in research, the app will ask for permission to access iPhone sensors 
like the accelerometer, gyroscope and other tools as a way to monitor 
activity. Participants can also opt in to share details about weight, 
blood pressure and glucose levels, so researchers can more closely 
examine how those relate to conditions and overall health.
The
 opening up of ResearchKit comes just as Apple set the date for its 
annual Worldwide Developers Conference (June 8-12), which — for $1,599 —
 grants developers access to five days of sessions, labs and special 
events centered on building software for iOS and the Mac. While selfie 
sticks are banned from its premises this year, the event will likely 
serve as ample breeding ground for mobile innovation.
Posted by : Gizmeon
No comments:
Post a Comment